Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the control of type 2 diabetes. This drug works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://dillannfyr886473.blogchaat.com/39227927/trelaglutide-exploring-a-new-treatment-for-chronic-diseases